Atlas Trials

Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome

Clinical trial NCT00721279 · COMPLETED

Trial details

NCT number
NCT00721279
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Restless Legs Syndrome
Start date
2007-09-01
Primary completion
2008-10-01
Enrollment
549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.